Respiratory Syncytial Virus Infection Rates with Limited Use of Palivizumab for Infants Born at 29 to 31+6/7 Weeks Gestational Age.
about
Respiratory Syncytial Virus Infection Rates with Limited Use of Palivizumab for Infants Born at 29 to 31+6/7 Weeks Gestational Age.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Respiratory Syncytial Virus In ...... 31+6/7 Weeks Gestational Age.
@en
Respiratory Syncytial Virus In ...... 31+6/7 Weeks Gestational Age.
@nl
type
label
Respiratory Syncytial Virus In ...... 31+6/7 Weeks Gestational Age.
@en
Respiratory Syncytial Virus In ...... 31+6/7 Weeks Gestational Age.
@nl
prefLabel
Respiratory Syncytial Virus In ...... 31+6/7 Weeks Gestational Age.
@en
Respiratory Syncytial Virus In ...... 31+6/7 Weeks Gestational Age.
@nl
P2860
P356
P1476
Respiratory Syncytial Virus In ...... o 31+6/7 Weeks Gestational Age
@en
P2093
Brandi Newby
Todd Sorokan
P2860
P356
10.4212/CJHP.V70I1.1623
P577
2017-01-01T00:00:00Z